CA125 (MUC16), CEA (CEACAM5), and HE4 (WFDC2) are clinically established diagnostic and prognostic markers of CESC; high levels of these biomarkers suggest cancer progression and poor prognosis (18, 19). The gene discussed is MUC16; the disease is cancer.